[1]
Rothe, K. et al. 2021. Dexamethasone therapy and rates of secondary pulmonary and bloodstream infections in critically ill COVID-19 patients. Multidisciplinary Respiratory Medicine. 16, (Oct. 2021). DOI:https://doi.org/10.4081/mrm.2021.793.